Maebius Quoted in World Intellectual Property Review About Aqua Products Decision
05 October 2017
World Intellectual Property Review
Partner Steve Maebius was quoted in “Petitioners Must Prove Unpatentability of Amended Claims in IPR,” published in the World Intellectual Property Review, about a recent U.S. Court of Appeals for the Federal Circuit decision, Aqua Products v Matal, which overturned a Patent Trial and Appeal Board ruling that had required patent owners to show the patentability of their amended claims in inter partes review.
Maebius told WIPR that “an outright reversal of the PTAB on this issue could substantially increase the workload for the PTAB, shifting its role more in the direction of having to examine and assess patentability of claims proposed by a patent owner.”
A reversal would be welcomed by patent owners, he added, who feel that the current bar is set too high.
Maebius told WIPR that “an outright reversal of the PTAB on this issue could substantially increase the workload for the PTAB, shifting its role more in the direction of having to examine and assess patentability of claims proposed by a patent owner.”
A reversal would be welcomed by patent owners, he added, who feel that the current bar is set too high.
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."